Trice Medical Names Hawkins to its Board of Directors.
M2 PHARMA-April 5, 2016-Trice Medical Names Hawkins to its Board of Directors
(C)2016 M2 COMMUNICATIONS
- US-based medical device company Trice Medical has appointed William Hawkins to the company's board of directors, effective 1 April 2016, the company said.
Hawkins' most recent position was with Immucor, Inc., where he served as its president and CEO from October 2011 to July 2015; currently, he is its Lead director.
Prior to joining Immucor, Hawkins served as chairman and CEO of Medtronic, one of the world's largest and most innovative medical technology companies. Hawkins' career spans more than three decades.
Before joining Medtronic, Hawkins was the CEO of Novoste, an Atlanta-based medical technology company.
Hawkins has a consistent track record of driving value-creating innovation that has revolutionized medical care and strengthened healthcare systems globally.
He has played a leadership role in Washington, DC on both healthcare policy and with matters involving the FDA.
Trice Medical was founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payor by providing instant, eyes-on, answers.
The company has developed fully integrated camera-enabled technology, the mi-eye+, that provides a clinical solution optimized for the physician's office.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 5, 2016|
|Previous Article:||NeoChord Names Martin to its Board of Directors.|
|Next Article:||Medical Device Maker Zyga Technology Enrolls First Patients in Sacroiliac Joint Fusion.|